Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Verrutop
- Development stage
- Unknown
- Lead developer
- ISDIN
- Administration
- Topical
01
Overview
**Verrutop** is a professionally applied topical medical-device treatment for difficult cutaneous warts. It is supplied as a Nitrizinc Complex solution containing nitric acid, organic acids, and zinc and copper salts. On contact with wart tissue, the acid-and-metal-ion formulation produces a local chemical reaction that devitalizes, dehydrates, and mummifies the lesion, allowing the wart to detach as healthy tissue regenerates. It is marketed for professional treatment of cutaneous, palmoplantar, periungual, and genital warts; Allderma markets the product in the Nordic region. ([allderma.se](https://allderma.se/en/product-areas/))
- Brand names
- Verrutop
Beyond the preview
Go deeper on Verrutop.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Verrutop.